Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
-
* Corresponding author: Dimitrios T Boumpas boumpasd@med.uoc.gr
- † Equal contributors
Arthritis Research & Therapy 2009, 11:R131 doi:10.1186/ar2798
Accesses
- Last 30 days: 70 accesses
- Last year: 852 accesses
- All time: 3613 accesses
Cited by
BioMed Central: 1 citation
|
Editorial
Rituximab treatment in rheumatoid arthritis: how does it work? Maria JH Boumans, Paul P Tak Arthritis Research & Therapy 2009, 11:134 (24 November 2009) |
